The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to notify clinicians and health departments about the occurrence, geographic spread, and sexually associated human-to-human transmission of Clade I Monkeypox virus (MPXV) in the Democratic Republic of the Congo (DRC) on December 7, 2023.
On December 7, 2023, BioPerfectus successfully obtained the Laboratory Accreditation Certificate from the China National Accreditation Service for Conformity Assessment (CNAS) with registration number CNAS L19654.
BioPerfectus was honored to host a distinguished delegation, including representatives from the Bill & Melinda Gates Foundation, PATH, Global Health Labs (GHLabs), and the Clinton Health Access Initiative (CHAI).
BioPerfectus extends a heartfelt welcome to the delegation led by the Consul General of Chile in Shanghai at Tai Zhou, Jiangsu, China.
BioPerfectus is committed to ongoing technological innovation and proudly offers the HPV 21 Type-specific Viral Loads Detection System to the world.
Dengue fever will become a major threat in the southern United States, southern Europe, and new parts of Africa this decade, the WHO's chief scientist said, as warmer temperatures create the conditions for the mosquitoes carrying the infection to spread.
BioPerfectus made a notable impression at the 20th Members' Meeting of the RHSC.
September is Gynecologic Cancer Awareness Month! Join us in raising awareness this month.
Today serves as a reminder to prioritize sexual health and foster positive attitudes toward consent.
Engaging talk with Prof. Élisée Ndam, Director of the Department of Pathology at the National Laboratory in Gabon. Our conversation delved into his research field, experiences with BioPerfectus, and future aspirations for collaboration.
